<DOC>
	<DOCNO>NCT00999908</DOCNO>
	<brief_summary>This study compare effect single dose indacaterol single dose tiotropium inspiratory capacity .</brief_summary>
	<brief_title>Comparison Effects Indacaterol Tiotropium Inspiratory Capacity</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Diagnosis moderate ( classified Global Initiative Chronic Obstructive Lung Disease [ GOLD ] Guidelines , 2007 ) chronic obstructive pulmonary disease ( COPD ) : 1 . Smoking history least 10 packyears . 2 . Forced expiratory volume 1 second ( FEV1 ) &lt; 80 % â‰¥ 50 % predict normal value . 3 . Postbronchodilator FEV1/Force vital capacity ( FVC ) &lt; 0.7 . Patients COPD exacerbation require systemic glucocorticosteroid treatment antibiotic and/or hospitalization 6 week prior screen . Patients respiratory tract infection within 6 week prior screen . Patients concomitant pulmonary disease . Patients alpha1antitrypsin deficiency . Patients contraindication tiotropium treatment . Patients history hypersensitivity study drug drug similar drug class . Other protocoldefined inclusion/exclusion criterion apply study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>COPD</keyword>
	<keyword>indacaterol</keyword>
	<keyword>tiotropium</keyword>
</DOC>